Neoadjuvant Treatment of Locoregional Metastases in Malignant Melanoma (AJCC Stage IIIB/C) With Multiferon: a Phase IIa DeCOG Trial.
Phase of Trial: Phase II
Latest Information Update: 12 Nov 2014
At a glance
- Drugs Interferon alpha (Primary)
- Indications Malignant melanoma
- Focus Biomarker; Therapeutic Use
- Acronyms NAM
- 30 Jun 2012 Company added in the association field as reported by EudraCT.
- 09 May 2012 New source identified and integrated (German Clinical Trials Register; DRKS00003619).
- 22 Feb 2012 New source identified and integrated (EudraCT2010-022103-21; European Clinical Trials Database).